Protein and Peptide Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: P74AF1649DE6EN
Market Monitor Global

Abstracts

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

This report contains market size and forecasts of Protein and Peptide Therapeutics in Global, including the following market information:

Global Protein and Peptide Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Protein and Peptide Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Protein and Peptide Therapeutics include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Protein and Peptide Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Protein and Peptide Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Protein and Peptide Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Injection
• Oral

Global Protein and Peptide Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Protein and Peptide Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Metabolic Disorders
• Central Nervous System
• Other

Global Protein and Peptide Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Protein and Peptide Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Protein and Peptide Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Protein and Peptide Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Teva
• Novo Nordisk
• Takeda
• Eli Lilly
• AstraZeneca
• Novartis
• AbbVie
• Ipsen
• Ferring
• Merck
• The Medicines
• J & J

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Protein and Peptide Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Protein and Peptide Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PROTEIN AND PEPTIDE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Protein and Peptide Therapeutics Market Size: 2021 VS 2028
2.2 Global Protein and Peptide Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Protein and Peptide Therapeutics Players in Global Market
3.2 Top Global Protein and Peptide Therapeutics Companies Ranked by Revenue
3.3 Global Protein and Peptide Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Protein and Peptide Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Protein and Peptide Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Protein and Peptide Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Protein and Peptide Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Protein and Peptide Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Protein and Peptide Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Injection
  4.1.3 Oral
4.2 By Type - Global Protein and Peptide Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Protein and Peptide Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Protein and Peptide Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Protein and Peptide Therapeutics Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Metabolic Disorders
  5.1.4 Central Nervous System
  5.1.5 Other
5.2 By Application - Global Protein and Peptide Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Protein and Peptide Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Protein and Peptide Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Protein and Peptide Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Protein and Peptide Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Protein and Peptide Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Protein and Peptide Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Protein and Peptide Therapeutics Revenue, 2017-2028
  6.3.2 US Protein and Peptide Therapeutics Market Size, 2017-2028
  6.3.3 Canada Protein and Peptide Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Protein and Peptide Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Protein and Peptide Therapeutics Revenue, 2017-2028
  6.4.2 Germany Protein and Peptide Therapeutics Market Size, 2017-2028
  6.4.3 France Protein and Peptide Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Protein and Peptide Therapeutics Market Size, 2017-2028
  6.4.5 Italy Protein and Peptide Therapeutics Market Size, 2017-2028
  6.4.6 Russia Protein and Peptide Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Protein and Peptide Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Protein and Peptide Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Protein and Peptide Therapeutics Revenue, 2017-2028
  6.5.2 China Protein and Peptide Therapeutics Market Size, 2017-2028
  6.5.3 Japan Protein and Peptide Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Protein and Peptide Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Protein and Peptide Therapeutics Market Size, 2017-2028
  6.5.6 India Protein and Peptide Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Protein and Peptide Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Protein and Peptide Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Protein and Peptide Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Protein and Peptide Therapeutics Market Size, 2017-2028
  6.7.3 Israel Protein and Peptide Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Protein and Peptide Therapeutics Market Size, 2017-2028
  6.7.5 UAE Protein and Peptide Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Protein and Peptide Therapeutics Major Product Offerings
  7.1.4 Sanofi Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Teva
  7.2.1 Teva Corporate Summary
  7.2.2 Teva Business Overview
  7.2.3 Teva Protein and Peptide Therapeutics Major Product Offerings
  7.2.4 Teva Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Teva Key News
7.3 Novo Nordisk
  7.3.1 Novo Nordisk Corporate Summary
  7.3.2 Novo Nordisk Business Overview
  7.3.3 Novo Nordisk Protein and Peptide Therapeutics Major Product Offerings
  7.3.4 Novo Nordisk Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Novo Nordisk Key News
7.4 Takeda
  7.4.1 Takeda Corporate Summary
  7.4.2 Takeda Business Overview
  7.4.3 Takeda Protein and Peptide Therapeutics Major Product Offerings
  7.4.4 Takeda Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Takeda Key News
7.5 Eli Lilly
  7.5.1 Eli Lilly Corporate Summary
  7.5.2 Eli Lilly Business Overview
  7.5.3 Eli Lilly Protein and Peptide Therapeutics Major Product Offerings
  7.5.4 Eli Lilly Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Protein and Peptide Therapeutics Major Product Offerings
  7.6.4 AstraZeneca Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Protein and Peptide Therapeutics Major Product Offerings
  7.7.4 Novartis Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 AbbVie
  7.8.1 AbbVie Corporate Summary
  7.8.2 AbbVie Business Overview
  7.8.3 AbbVie Protein and Peptide Therapeutics Major Product Offerings
  7.8.4 AbbVie Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 AbbVie Key News
7.9 Ipsen
  7.9.1 Ipsen Corporate Summary
  7.9.2 Ipsen Business Overview
  7.9.3 Ipsen Protein and Peptide Therapeutics Major Product Offerings
  7.9.4 Ipsen Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Ipsen Key News
7.10 Ferring
  7.10.1 Ferring Corporate Summary
  7.10.2 Ferring Business Overview
  7.10.3 Ferring Protein and Peptide Therapeutics Major Product Offerings
  7.10.4 Ferring Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Ferring Key News
7.11 Merck
  7.11.1 Merck Corporate Summary
  7.11.2 Merck Business Overview
  7.11.3 Merck Protein and Peptide Therapeutics Major Product Offerings
  7.11.4 Merck Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Merck Key News
7.12 The Medicines
  7.12.1 The Medicines Corporate Summary
  7.12.2 The Medicines Business Overview
  7.12.3 The Medicines Protein and Peptide Therapeutics Major Product Offerings
  7.12.4 The Medicines Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 The Medicines Key News
7.13 J & J
  7.13.1 J & J Corporate Summary
  7.13.2 J & J Business Overview
  7.13.3 J & J Protein and Peptide Therapeutics Major Product Offerings
  7.13.4 J & J Protein and Peptide Therapeutics Revenue in Global Market (2017-2022)
  7.13.5 J & J Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Protein and Peptide Therapeutics Market Opportunities & Trends in Global Market
Table 2. Protein and Peptide Therapeutics Market Drivers in Global Market
Table 3. Protein and Peptide Therapeutics Market Restraints in Global Market
Table 4. Key Players of Protein and Peptide Therapeutics in Global Market
Table 5. Top Protein and Peptide Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Protein and Peptide Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Protein and Peptide Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Protein and Peptide Therapeutics Product Type
Table 9. List of Global Tier 1 Protein and Peptide Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Protein and Peptide Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Protein and Peptide Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Protein and Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Protein and Peptide Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Protein and Peptide Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Protein and Peptide Therapeutics Product Offerings
Table 32. Sanofi Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Protein and Peptide Therapeutics Product Offerings
Table 35. Teva Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Novo Nordisk Corporate Summary
Table 37. Novo Nordisk Protein and Peptide Therapeutics Product Offerings
Table 38. Novo Nordisk Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Takeda Corporate Summary
Table 40. Takeda Protein and Peptide Therapeutics Product Offerings
Table 41. Takeda Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Protein and Peptide Therapeutics Product Offerings
Table 44. Eli Lilly Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Protein and Peptide Therapeutics Product Offerings
Table 47. AstraZeneca Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Protein and Peptide Therapeutics Product Offerings
Table 50. Novartis Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. AbbVie Corporate Summary
Table 52. AbbVie Protein and Peptide Therapeutics Product Offerings
Table 53. AbbVie Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Ipsen Corporate Summary
Table 55. Ipsen Protein and Peptide Therapeutics Product Offerings
Table 56. Ipsen Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Ferring Corporate Summary
Table 58. Ferring Protein and Peptide Therapeutics Product Offerings
Table 59. Ferring Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Merck Corporate Summary
Table 61. Merck Protein and Peptide Therapeutics Product Offerings
Table 62. Merck Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. The Medicines Corporate Summary
Table 64. The Medicines Protein and Peptide Therapeutics Product Offerings
Table 65. The Medicines Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. J & J Corporate Summary
Table 67. J & J Protein and Peptide Therapeutics Product Offerings
Table 68. J & J Protein and Peptide Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Protein and Peptide Therapeutics Segment by Type in 2021
Figure 2. Protein and Peptide Therapeutics Segment by Application in 2021
Figure 3. Global Protein and Peptide Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Protein and Peptide Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Protein and Peptide Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Protein and Peptide Therapeutics Revenue in 2021
Figure 8. By Type - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Protein and Peptide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novo Nordisk Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takeda Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AbbVie Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ipsen Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Ferring Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. The Medicines Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. J & J Protein and Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)